“White Bagging” Delays Care The experience of cancer patients in Indiana illustrates how the practice of white bagging delays patient care by days and weeks, sidetracks medical teams from direct patient care, burdens providers with tedious administrative burdens, and up-ends personalized treatment plans that physicians tailor for each cancer patient. White bagging is a health insurance directive that prohibits cancer

Support and Resources for Patients and Families When patients receive a cancer diagnosis they may feel like they’re in freefall, tumbling to an unknown place. With support and resources things begin to stabilize for both patients and their loved ones. The Leukemia & Lymphoma Society (LLS) is a steady source for support, resources and trusted information. Through one-on-one patient support,

No Time for Delay Research continues to uncover the impact of the COVID-19 pandemic on cancer diagnosis and treatment. The findings are troubling. Across all age groups there was a substantial decrease in cancer pathology reports in 2020 as compared to 2019. The age group that saw the steepest decline (38%) in biopsies and testing was under 18 years old.

COVID Vaccine Registry Data on Patients with Rheumatic Diseases Patients, caregivers and providers look through the lens of a complex chronic condition when considering medical care that others may consider routine or harmless. P+P United wanted to make sure those with diseases including rheumatoid arthritis, lupus and psoriatic arthritis and their caregivers and providers were aware of a recent analysis

Can a Body Undergoing Cancer Treatment Respond to COVID Vaccine Too? Cancer treatment can tax the body and push the limits of tolerability. However, a new study published in JAMA Oncology affirms that even adult patients in the midst of cancer treatment mount an adequate immune response from mRNA COVID 19 vaccines. That means, although patients may not feel they

Looking Back – Far Back – to Better Understand Cancer Researchers from the University of Arizona and Australian National University are challenging the standard model of cancer by examining the ancient underpinnings of the disease. The research is driven by the idea expressed by cancer biologist, Anneke Blackburn, that “A better understanding of cancer can lead to better therapeutic outcomes.”